Physician profile
Kayla Lash
NPI 1295120772
$1,101.02
in general payments reported to CMS, 2019-2025
10 companies · $160 in 2025
The $160 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $249 · 2021: $118 · 2022: $269 · 2023: $242 · 2024: $62.18 · 2025: $160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $465.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $464.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $299.15 | 2022-2025 | Coolseal Generator, Acessa Provu System, Thinprep 2000 Processor |
| Pacira Pharmaceuticals Incorporated | $242.56 | 2021-2023 | Exparel |
| Boston Scientific Corporation | $126.42 | 2019 | |
| Abbvie INC. | $122.19 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $109.82 | 2025 | |
| Gynesonics, INC. | $58.22 | 2022 | |
| Organon LLC | $44.02 | 2022-2024 | |
| Coopersurgical, INC. | $37.20 | 2022 | |
| Bolder Surgical, LLC | $33.62 | 2022 | |
| Smith+Nephew, INC. | $27.82 | 2025 | Pico 14, Pico 7 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kayla Lash listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.